Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Alx Oncology Holdings Inc (ALXO)

Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 68,038
  • Shares Outstanding, K 52,743
  • Annual Sales, $ 0 K
  • Annual Income, $ -160,810 K
  • EBIT $ -160 M
  • EBITDA $ -165 M
  • 60-Month Beta 1.03
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.51

Options Overview Details

View History
  • Implied Volatility 187.18% ( -166.98%)
  • Historical Volatility 74.99%
  • IV Percentile 80%
  • IV Rank 33.85%
  • IV High 528.24% on 08/26/24
  • IV Low 12.65% on 10/22/24
  • Put/Call Vol Ratio 5.62
  • Today's Volume 417
  • Volume Avg (30-Day) 55
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 1,442
  • Open Int (30-Day) 3,387

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.69
  • Number of Estimates 5
  • High Estimate -0.57
  • Low Estimate -0.81
  • Prior Year -0.93
  • Growth Rate Est. (year over year) +25.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2300 +0.41%
on 11/18/24
1.7696 -30.21%
on 10/23/24
-0.2450 (-16.55%)
since 10/18/24
3-Month
1.2300 +0.41%
on 11/18/24
2.7300 -54.76%
on 08/20/24
-1.3050 (-51.38%)
since 08/16/24
52-Week
1.2300 +0.41%
on 11/18/24
17.8250 -93.07%
on 05/07/24
-8.2650 (-87.00%)
since 11/17/23

Most Recent Stories

More News
ALX Oncology Appoints Alan Sandler, M.D., as Chief Medical Officer

ALXO : 1.2200 (-5.43%)
ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

ALXO : 1.2200 (-5.43%)
ALX Oncology Announces November Investor Conference Participation

ALXO : 1.2200 (-5.43%)
ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with Zanidatamab will be Presented at the San Antonio Breast Cancer Symposium (SABCS) 2024

ALXO : 1.2200 (-5.43%)
Why ALX Oncology Stock Is Skyrocketing Today

Investors are cheering the immuno-oncology company's latest clinical trial results.

ALXO : 1.2200 (-5.43%)
Stock Index Futures Plunge Ahead of U.S. JOLTs Report, U.S. Rates Stay in Focus

December S&P 500 futures (ESZ23) are down -0.38%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.50% this morning as market participants looked ahead to the release of fresh labor market data...

ESZ23 : 4,694.27s (-0.58%)
NQZ23 : 16,530.23s (-0.07%)
NVDA : 140.15 (-1.29%)
META : 554.40 (+0.06%)
GOOGL : 175.30 (+1.63%)
PODD : 260.68 (+0.22%)
K : 80.60 (+0.04%)
TGT : 156.56 (+2.91%)
BOO.LN : 29.660 (-1.13%)
ZAL.D.DX : 27.520 (+0.07%)
ALXO : 1.2200 (-5.43%)
ODD : 39.71 (-0.10%)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

NetworkNewsWire Editorial Coverage : More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation...

GNPX : 1.3600 (-15.00%)
RHHBY : 35.7020 (-0.39%)
JAZZ : 117.59 (-3.34%)
ALXO : 1.2200 (-5.43%)
ACHL : 1.0500 (unch)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

NetworkNewsWire Editorial Coverage : More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation...

GNPX : 1.3600 (-15.00%)
RHHBY : 35.7020 (-0.39%)
JAZZ : 117.59 (-3.34%)
ALXO : 1.2200 (-5.43%)
ACHL : 1.0500 (unch)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

EQNX::TICKER_START (NASDAQ:GNPX),(OTCQX:RHHBY),(NASDAQ:JAZZ),(NASDAQ:ALXO),(NASDAQ:ACHL) EQNX::TICKER_END

GNPX : 1.3600 (-15.00%)
RHHBY : 35.7020 (-0.39%)
JAZZ : 117.59 (-3.34%)
ALXO : 1.2200 (-5.43%)
ACHL : 1.0500 (unch)
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

/PRNewswire/ -- More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the...

RHHBY : 35.7020 (-0.39%)
GNPX : 1.3600 (-15.00%)
JAZZ : 117.59 (-3.34%)
ALXO : 1.2200 (-5.43%)
ACHL : 1.0500 (unch)

Business Summary

ALX Oncology Holdings Inc.is a clinical-stage immuno-oncology company. It focuses on developing therapies for patients fighting cancer. The company's product candidate consist ALX148, which is in clinical stage. ALX Oncology Holdings Inc.is based in Burlingame, California.

See More

Key Turning Points

3rd Resistance Point 1.4433
2nd Resistance Point 1.3967
1st Resistance Point 1.3433
Last Price 1.2200
1st Support Level 1.2433
2nd Support Level 1.1967
3rd Support Level 1.1433

See More

52-Week High 17.8250
Fibonacci 61.8% 11.4857
Fibonacci 50% 9.5275
Fibonacci 38.2% 7.5693
Last Price 1.2200
52-Week Low 1.2300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar